Report Highlights
The global markets and technologies for optical coherence tomography (OCT) should reach $1.5 billion by 2023 from $993.9 million in 2018 at a compound annual growth rate (CAGR) of 8.8% for the period of 2018 to 2023.
Report Includes
- 15 data tables and 34 additional tables
- An overview of the global market for optical coherence tomography (OCT)
- Analyses of global market trends, with data from 2017 to 2018, and projections of CAGRs through 2023
- Comparative study of traditional/time domain (TD-OCT), frequency domain (FD-OCT), and polarization sensitive (PD-OCT) OCT and discussion of their characteristics
- Insights into significant funding initiatives from government agencies and regulatory framework
- Discussion of technological advancement and growing adoption rate of OCT
- Comprehensive company profiles of major players, including Abbott Laboratories, Canon, Heidelberg Engineering, Nikon Corp., Phoenix Research Labs, Thorlabs Inc. and Topcon
Report Scope
The current report offers a detailed analysis of the optical coherence tomography market. The study includes a discussion of OCT products used for medical and non-medical applications.
The report highlights the current market and future market potential of optical coherence tomography, and provides a detailed analysis of the competitive environment, regulatory scenario, patent analysis, drivers and restraints in the market. The report also covers market projections through 2023, as well as key players in the global OCT market.
The report details market shares of optical coherence tomography based on product, application and geography. Based on product, the market is segmented into traditional OCT/time domain (TD-OCT), frequency domain OCT (FD-OCT) and other OCT products. The frequency domain OCT (FD-OCT) is sub -segmented into Fourier domain or spectral domain (SD-OCT) and time-encoded frequency domain or Swept-Source (TEFD-OCT/SS-OCT). The other OCT product segment includes polarization sensitive OCT (PS-OCT), full-field optical coherence tomography (FF-OCT) and optical delay line.
Based on application, the market is segmented into ophthalmology, cardiology, oncology and other applications. The other applications segment includes other medical and non-medical application areas of OCT technology.
The market is segmented by geography into the following regions: North America, Europe and the Rest of the World. For market estimates, data is provided for 2017 as the base year, with forecasts for 2018 through 2023. Estimated values are based on manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Alzheimer's Disease Therapeutics and Diagnostics: Global Markets (PHM062E)
- Impact Modifiers: Global Markets (AVM252A)
- Adhesives and Adhesive-Applying Equipment: Technologies and Global Markets (CHM073E)
- Bioprocess Optimization and Digital Bio-manufacturing: Global Markets (BIO170B)
- Metal-organic Frameworks: Global Markets (AVM200B)
Report Highlights
The global market for optical coherence tomography technologies reached $722.7 million and $795.4 million in 2013 and 2014, respectively. This market is forecasted to grow at a compound annual growth rate (CAGR) of 7.9% to reach nearly $1.2 billion in 2019.
Report Includes
- An overview of the global market for optical coherence tomography (OCT), including details on system technology segments: traditional (time domain), frequency domain, and other modes of OCT measurement.
- Analyses of global market trends, with data from 2013 and 2014 and projections of CAGRs through 2019.
- A breakdown of OCT formats, including office/tabletop, catheter-based, and handheld.
- Regulatory status of the devices in the U.S., EU, and other regions.
- Delineation of the major markets for the technology, including ophthalmology, cardiovascular, oncology, dermatology, and dental applications.
Report Highlights
The global market for optical coherence tomography (OCT) grew from $580.8 million in 2011 to $645.4 million in 2012 and is predicted to increase to nearly $1.1 billion by 2017, at a CAGR of 10.4% from 2012 to 2017.
Report Includes
- An overview of the global market for optical coherence tomography (OCT), including details on system technology segments: traditional (time domain), frequency domain, and other modes of OCT measurement.
- Analyses of global market trends, with data from 2010 to 2012, and projections of compound annual growth rates (CAGRs) through 2017.
- A breakdown of OCT formats, including office/tabletop, catheter-based, and handheld.
- Regulatory status of the devices in the U.S., EU, and other regions.
- Delineation of the major markets for the technology, including ophthalmology, cardiovascular, oncology, dermatology, and dental applications.
- Comprehensive company profiles of major players.
Related Reports
4D Imaging in Healthcare
The global market for 4D imaging in healthcare is estimated to grow from $8.1 billion in 2022 to $16.7 billion in 2027, with a compound annual growth rate (CAGR) of 15.3% for the period of 2022-2027.
Dental Imaging Systems: Global Markets
The global market for dental imaging systems is estimated to increase from $3.5 billion in 2022 to $5.5 billion by 2027, at a compound annual growth rate (CAGR) of 9.3% during the forecast period of 2022-2027.
Advanced Image-guided Surgery Systems
This report provides a brief description of advanced image-guided surgery (IGS) systems, also known as surgical navigation, and their applications in medicine and dentistry. Recent innovations and current and emerging trends in IGS technology will also be assessed.
Biophotonics: Technologies and Global Markets
The global biophotonics market should grow from $32.2 billion in 2016, by a five year compound annual growth rate (CAGR) of 10.8%, to reach nearly $53.8 billion in 2021.
Recent Reports
Surgical Equipment: Technologies and Global Markets
The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More